An engineering breakthrough in Type 1 diabetes could help dogs and humans alike. The disease affects about one in every 100 companion animals in the U.S., including dogs and cats, and approximately 1.25 million American children and adults. Purdue engineers in collaboration with the Indiana University School of Medicine, with funding from the National Science Foundation, are developing a new therapy that could replace the need for daily insulin injections for both canines and humans. The therapy has the potential to reduce the number of shots to one every few months. This breakthrough could make managing the disease much easier.
Provided by National Science Foundation